Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist is a research paper published in Handbook of experimental pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDA NIH HHS
Grant: P30 DA013429
NIDA NIH HHS
Grant: R21 DA045274
NIDA NIH HHS
Grant: F30 DA044711
NIDA NIH HHS
Grant: R01 DA039167
NIDA NIH HHS
Grant: R01 DA041359
National Institutes of Health
Grant: 2P30DA013429-06
ADMINISTRATIVE CORE
National Institutes of Health
Grant: 5R01DA039167-07
Deterrents for prescription opioid abuse
National Institutes of Health
Grant: 3R01DA041359-05S1
Pharmacology of Kappa Opioid Receptor
National Institutes of Health
Grant: 1F30DA044711-01A1
Role of Regulator of G-protein Signaling-12 (RGS12) in morphine modulated behavior
National Institutes of Health
Grant: 1R21DA045274-01
Kappa opioid receptor in claustrum
FWCI
15.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals